Signaling Pathways - Serine Proteases - RET - Androgen Receptors - Animal Experiments
清除全部
-
A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂 -
B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂 -
A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体（AR）拮抗剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂 -
A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体（Androgen receptor）拮抗剂 -
A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂 -
A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂 -
A2587 PMSF1 Citation中文名: 苯甲基磺酰氟Target: Serine ProteasesSummary: 丝氨酸蛋白酶不可逆抑制剂 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂